Management of immune checkpoint inhibitor–related acute hypoxic neuromuscular respiratory failure using high-flow nasal cannula

Essie P. MathewsDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas; Correspondence[email protected]

, DNP, APRN, ACNP-BC &

Jia W. RomitoDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas; ;Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas; ;Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, Texas

, MD

Psimaras D, Velasco R, Birzu C, et al. Immune checkpoint inhibitors–induced neuromuscular toxicity: from pathogenesis to treatment. J Peripher Nerv Syst. 2019;24(S2):S74–S85. doi:10.1111/jns.12339.
Google Scholar
Puwanant A, Isfort M, Lacomis D, et al. Clinical spectrum of neuromuscular complications after immune checkpoint inhibition. Neuromuscul Disord. 2019;29(2):127–133. doi:10.1016/j.nmd.2018.11.012.
PubMed Web of Science ®Google Scholar
Díaz-Lobato S, Folgado MA, Chapa A, et al. Efficacy of high-flow oxygen by nasal cannula with active humidification in a patient with acute respiratory failure of neuromuscular origin. Respir Care. 2013;58(12):e164–e167. doi:10.4187/respcare.02115.
Google Scholar
Anquetil C, Salem J-E, Lebrun-Vignes B, et al. Immune checkpoint inhibitor–associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution. Circulation. 2018;138(7):743–745. doi:10.1161/CIRCULATIONAHA.118.035898.
PubMed Web of Science ®Google Scholar
Helviz Y, Einav S. A systematic review of the high-flow nasal cannula for adult patients. Critic Care. 2018;22(1):71. doi:10.1186/s13054-018-1990-4.
PubMedGoogle Scholar
Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529–541. doi:10.4187/respcare.04577.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Management of immune checkpoint inhibitor–related acute hypoxic neuromuscular respiratory failure using high-flow nasal cannula

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Management of immune checkpoint inhibitor–related acute hypoxic neuromuscular respiratory failure using high-flow nasal cannula

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date